HHM Wealth Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

HHM Wealth Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-126	Closed	–	–	847
2022 Q2	$0	Sell	126 -1	-0.8%	-$2	﹤0.01%	866
2022 Q1	$1K	Hold	127	–	–	﹤0.01%	693
2021 Q4	$1K	Hold	127	–	–	﹤0.01%	667
2021 Q3	$1K	Hold	127	–	–	﹤0.01%	621
2021 Q2	$2K	Buy	+127	New	+$2.41K	﹤0.01%	587

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

HHM Wealth Advisors's EVFM Position: Q3 2022 in Review

HHM Wealth Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 126 shares.

HHM Wealth Advisors first reported a position in EVFM in Q2 2021 and held it in 5 quarters. The position peaked at $2K in Q2 2021. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

HHM Wealth Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
HHM Wealth Advisors sold 126 Evofem Biosciences, Inc. Common Stock shares in Q3 2022.
HHM Wealth Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
HHM Wealth Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $2K in Q2 2021.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on HHM Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.